Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Arcus Biosciences, Inc. (NYSE: RCUS)
RCUS Stock Predictions and Ratings
WSX Rating:
STRONG BUY
WSX Forecast (1yr):
38.20%
Analyst Rating:
BUY
Analyst Forecast (1yr):
18.60%
RCUS Stock Analysis
RCUS
PE Ratio:
RCUS
PEG Ratio:
Not Available
RCUS
Forward EPS Growth (12 month):
0.00%
RCUS
PS Ratio:
10.2
RCUS
PSG Ratio:
0.2
RCUS
Forward Revenue Growth (12 month):
47.90%
RCUS Articles
No data was found